ArticleCancer immunology research2025

Alternate MHC I Antigen Presentation Pathways Allow CD8+ T-cell Recognition and Killing of Cancer Cells in the Absence of β2M or TAP.

Freidrich M Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.